Medispec Shockwave Devices: Efficacy & Alternatives

Shockwave therapy has expanded across orthopedic, regenerative, and urologic care, yet devices differ in energy generation, treatment field size and shape, and dosing reproducibility. Many platforms are described as if they deliver comparable biological effects even when depth and tissue coverage vary across designs.

Medispec shockwave devices are marketed across multiple service lines, with device-named studies appearing most often in sexual health and urologic applications and less frequently in musculoskeletal literature. For clinicians, knowing where the evidence base is concentrated, where outcomes are inferred from broader modality research, and where technical claims lack independent characterization helps set expectations for protocol development and cross-specialty use.

What Medispec Shockwave Devices Claim To Be

Medispec shockwave devices are presented as extracorporeal platforms offered across multiple service lines. In manufacturer descriptions, Medispec includes radial wave systems intended for more superficial orthopedic use, focused shockwave systems positioned for more localized energy delivery, and systems marketed with a Multi-Wave reflector concept that distributes energy across a broader treatment zone.

In Medispec positioning, these configurations are referenced across orthopedics and rehabilitation, sexual medicine and pelvic health, and urology workflows that include stone management. Device-named publications from the past decade most often reference Medispec systems in sexual health protocols and lithotripsy cohorts, whereas musculoskeletal publications that clearly name Medispec hardware appear less frequently in the peer-reviewed record.

Only a few points about Medispec can be stated with confidence: 

• Device-named studies most often evaluate Medispec systems in sexual medicine and urology cohorts, including vestibulodynia, post-prostatectomy erectile dysfunction protocols, and lithotripsy workflows. Gruenwald et al. (2021), Kohada et al. (2023), Lee et al. (2018).
• Reported endpoints in these device-named publications commonly focus on clinical outcomes such as symptom scores, functional measures, and procedural success rates, while independent mapping of treatment field geometry and depth-specific distribution is less often reported in a way that supports protocol transfer across anatomical regions.
• Medispec marketing references Multi-Wave field concepts, yet open literature that independently characterizes the Multi-Wave distribution and tissue volume engagement for specific Medispec applicators remains limited relative to the scope of indications listed across the product portfolio.

Where Radial and Focused Shockwave Have Evidence in the Literature

Radial and focused shockwaves have been evaluated across multiple musculoskeletal populations, although outcomes vary across protocols, dosing strategies, co-interventions, and clinical endpoints.

These effects have been described in peer-reviewed studies:

• Plantar fasciopathy trial comparing radial ESWT, sham rESWT, or exercise added to advice and custom orthoses, reporting no added improvement over advice plus orthoses alone. Heide et al. (2024)
• Chronic plantar fasciitis randomized trial where radial ESWT device appearance did not influence outcomes, using patient-reported outcomes and ultrasound measures. Morral et al. (2019)
• Chronic plantar fasciopathy randomized trial comparing recommended dose radial ESWT with minimal dose, reporting within-group improvement without between-group difference. Wheeler et al. (2022)
• Lateral epicondylitis randomized trial comparing focused shockwave with ultrasound therapy, reporting changes in pain and function outcomes. Król et al. (2024)
• Greater trochanteric pain syndrome randomized trial comparing focused shockwave therapy with ultrasound-guided corticosteroid injection using pain and function measures. Heaver et al. (2021)
• Bone stress injury runner series describing return-to-run outcomes after focused shockwave use in a clinical setting. Beling et al. (2023)

These findings reflect the broader radial and focused shockwave literature. They do not confirm device-specific output or treatment field geometry unless a named system, such as Medispec, is independently characterized. Operational and study design constraints that can limit protocol transfer across clinics and anatomical regions include the following:

• Clinical response patterns can vary with dose selection and protocol design, such as energy level, pulse number, session spacing, use of imaging guidance, and the rehab plan delivered alongside Shockwave.
• Many publications list dose settings but do not describe the emitted field in practical terms, such as treatment zone dimensions, depth profile, or estimated tissue volume exposed, which limits reproducibility when translating protocols to different anatomic regions.
• Outcomes are commonly anchored in pain and functional scales, while objective correlates such as imaging findings or tissue-level measures are reported less consistently across cohorts.
• Follow-up is often limited to short or intermediate time points, which supports interpretation of near-term change while leaving longer-term durability less consistently defined across studies.
• Medispec references a Multi-Wave approach in marketing materials, yet independent peer-reviewed publications that characterize a Medispec Multi-Wave field and quantify distribution and tissue volume engagement are not available in open literature relative to the breadth of indications described across the product portfolio.

Read: Radial Shockwave Therapy Benefits & Alternatives

Medispec Shockwave Devices in Clinical Context and What Is Missing

Device-named Medispec publications can inform select sexual medicine and urology workflows, yet several evidence and reporting gaps remain when clinicians are building repeatable regenerative pathways across varied anatomy and symptom patterns.

1. Limited Indication Breadth in Device-Named Studies

Device-named Medispec studies cluster in sexual health, pelvic pain, erectile dysfunction protocols, and lithotripsy cohorts. This leaves fewer device-named data points for the wider orthopedic and regenerative indications described across the portfolio.

2. Outcome Reporting That Is Often Symptom or Procedure-Centered

Endpoints commonly emphasize symptom scales, functional measures, sexual function questionnaires, or stone clearance metrics. Objective tissue-level correlates and imaging endpoints are reported less consistently across device-named cohorts.

3. Limited Independent Characterization of Treatment Field and Tissue Volume Engagement

Many reports list dose variables such as energy level, pulse count, and session cadence. Independent characterization of field size, depth distribution, and tissue volume engagement is less consistently available for protocol translation across regions.

4. Multi-Wave Claims With Limited Public Independent Validation

Medispec references a Multi-Wave approach in manufacturer materials. Independent, peer-reviewed publications that characterize the Multi-Wave field and quantify its distribution and tissue volume engagement appear limited in the open literature.

5. Evidence Concentration Relative to Broad Orthopedic Positioning

Device-named evidence appears more concentrated in urology and sexual health than in musculoskeletal cohorts. This can influence how confidently a clinic extends a single platform across multiple service lines.

These gaps do not negate the outcomes reported in the studied cohorts. They mainly shape how confidently protocols translate across regions and how reproducible dosing is likely to be in multifocal presentations.

Why Broad-Focused Shockwave Design Is Increasingly Used in Regenerative Care

Broad-focused shockwave systems have gained clinical adoption because they engage a wider biological environment and accommodate the layered nature of many musculoskeletal injuries. Clinicians use this approach when multiple tissues contribute to symptoms, especially in regions where pain patterns span a continuum rather than one discrete point.

A broad-focused field supports consistent coverage across superficial and deeper tissue planes during the same application. This matters in clinical practice because it supports repeatable dosing across a region, reduces dependence on pinpoint localization, and aligns with workflows that treat complex presentations across multiple anatomical structures.

Clinically relevant advantages associated with broad focused designs include:

• Engagement of a larger and deeper biological environment that supports mechanotransduction across interconnected tissues
• Higher patient tolerance that supports delivery of clinically meaningful dosing without pronounced discomfort
• Reduced dependence on exact handpiece placement, improving reproducibility across providers
• Practical fit across multidisciplinary workflows in orthopedics, sports medicine, physiatry, podiatry, physical therapy, wound care, and pelvic health

SoftWave Therapy: A Broad Focused Shockwave System With Multidisciplinary Validation

SoftWave Therapy is a patented, broad-focused shockwave system designed for in-office clinical use. It uses an electrohydraulic source with a patented parabolic reflector to generate a broad therapeutic field measuring roughly 7 cm by 12 cm, supporting simultaneous engagement of superficial and deeper tissues within a single application. This field architecture supports the treatment of layered anatomical regions where symptoms involve interconnected soft tissue and connective tissue structures.

The broad-focused field produced through this electrohydraulic design is associated with biologic responses relevant to tissue repair, including modulation of inflammation, activation of connective tissue, and promotion of neovascularization. Because energy is distributed across a broad zone rather than concentrated into a single focal point, SoftWave protocols are commonly associated with high patient tolerance and consistent completion of multi-session care plans.

SoftWave has received FDA 510(k) clearances for: activation of connective tissue, temporary increase in blood flow, temporary pain relief, treatment of chronic diabetic foot ulcers, and treatment of acute second-degree burns. The system is designed exclusively for clinical settings and has been integrated across specialties, including orthopedics, podiatry, sports medicine, physical therapy, urology, and wound care.

For clinicians, the distinction lies in coverage and platform efficiency. Radial and focused devices generally treat smaller zones per application, while SoftWave engages a wider surrounding tissue environment in a single session using a single in-office system, supported through FDA-cleared indications and device-specific clinical validation.

How Clinicians Compare Shockwave Devices When Selecting a Platform

Device selection in shockwave medicine typically focuses on parameters that determine whether protocols translate reliably across clinicians, anatomies, and service lines. The goal is consistent tissue engagement, tolerable dosing, and evidence alignment with the clinic’s primary indications.

Key criteria many clinicians use include:

1. Treatment field size and shape, including how much tissue is exposed per application
2. Depth profile and ability to engage superficial and deeper structures within the same session
3. Patient tolerance at dosing levels used in real-world protocols
4. Regulatory status and cleared indications relevant to the practice
5. Quality and quantity of device-named clinical validation, including follow-up duration
6. Operator dependence and how sensitive outcomes are to exact targeting and technique
7. Multidisciplinary fit within one platform across orthopedics, sports medicine, podiatry, physical therapy, wound care, and pelvic health
8. Workflow factors such as session time, cadence, consumables, maintenance demands, and training requirements

Together, these factors enable side-by-side evaluation of systems optimized for localized targets versus platforms engineered for wider field engagement, helping clinicians select technology that aligns with their most common presentations and practice model.

Choosing the Right Shockwave System for In-Office Regenerative Care

Medispec is positioned across multiple service lines and is marketed across three delivery approaches that clinicians commonly see referenced, radial wave therapy, focused shockwave delivery, and a Multi-Wave reflector concept described in manufacturer materials. Device-named publications appear most often in sexual medicine and urologic workflows and are less represented across the full range of orthopedic indications referenced in broader portfolio positioning. Radial and focused shockwave therapy, as broader categories, have supportive evidence in defined musculoskeletal cohorts, though designs that treat smaller zones per application can shape efficiency and coverage in regional presentations.

Broad-focused electrohydraulic systems such as SoftWave engage larger tissue volumes through a single in-office device, support multidisciplinary practice integration, and are backed by FDA-cleared indications and stronger device-specific clinical validation. These distinctions help clinicians select shockwave technology aligned with regenerative goals, workflow efficiency, and patient tolerance.

Learn more about the Best Shockwave Therapy Machine for Providers.

Integrate SoftWave Into Multidisciplinary Workflows

SoftWave combines a patented broad-focused shockwave design with an electrohydraulic source and parabolic reflector that supports wide, deep tissue engagement in a single in-office session. For clinics building regenerative care pathways across orthopedics, sports medicine, podiatry, physical therapy, wound care, or pelvic health, SoftWave supports consistent protocols, high patient tolerance, and multidisciplinary integration, backed by FDA-cleared indications and device-specific clinical validation.

Learn more about SoftWave clinical research.

Become a SoftWave Provider Today